RE: Surely there is still a need for an antigen test.15 May 2020 10:25
The AB is a "nice to have" but at this current stage of the epidemic we need to know who is infectious right NOW.
From the BBC article yesterday:
"The swab tests currently being carried out in the UK determine whether someone has the virus at the time of the test. These will remain the core part of the government's test, track and trace strategy for containing the spread of the virus."
Thanks Parkez, read that a couple of weeks ago very interesting isn't it. We are lucky to be a leader in testing that we will be able to roll this out to the masses and get this test in hands across the globe. Going to make a real difference I feel.
Expect this to land tomorrow. Look at the direct quotes below from assistant to director general at the WHO.
WHO, in a statement posted on its website, said the move should help increase access to quality-assured, accurate tests for the disease.
“It also means that the tests can now be supplied by the United Nations and other procurement agencies supporting the COVID-19 response.
“Both in vitro diagnostics, the tests are genesig Real-Time PCR Coronavirus (COVID-19) and cobas SARS-CoV-2 Qualitative assay for use on the cobas® 6800/8800 Systems. “
The emergency use listing of these products will enable countries to increase testing with quality assured diagnostics.
“Facilitating access to accurate tests is essential for countries to address the pandemic with the best tools possible,” says Dr Mariângela Simão, WHO Assistant-Director General for Medicines and Health Products The Emergency Use Listing procedure (EUL) was established to expedite the availability of diagnostics needed in public health emergency situations.
1) Direct-to-PCR extraction (notice that the media are now picking up on this... see below from Proactive Investors today)
Novacyt PLC (LON:NCYT) has been one of the pioneers in swab testing, launching the first kit in February, followed by a second one, designed to deliver faster results, in March. It is manufacturing 4mln tests per month. It is also developing a new test that does not require certain extraction reagents which are lacking throughout the market.
2) Ramp up in manufacture to 8 million tests a month
3) Cambridge lab running at full tilt, 30,000 tests a day. Involvement in Alderly Park, Milton Keynes through our partnership with AZ.